SynCore Biotechnology Co

SynCore Biotechnology Co FCF Growth

The Year-over-Year Free Cash Flow Growth of SynCore Biotechnology Co (4192.TWO) as of Nov 17, 2026 is 22.05 %. In the previous year, Year-over-Year Free Cash Flow Growth was 40.22 % — a change of -45.17% (lower).

FCF Growth

22.05 %

YoY

-45.17%

Last updated:

Year-over-Year Free Cash Flow Growth of SynCore Biotechnology Co is 2025 22.05 % . Year-over-Year Free Cash Flow Growth of SynCore Biotechnology Co was 2024 40.22 % . It decreases by -45.17% lower compared to the previous year.

The SynCore Biotechnology Co FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2018
-28.55 TWD
Jan 1, 2019
-53.36 TWD
Jan 1, 2020
23.56 TWD
Jan 1, 2021
28.25 TWD
Jan 1, 2022
9.01 TWD
Jan 1, 2023
60.53 TWD
Jan 1, 2024
40.22 TWD
Jan 1, 2025
22.05 TWD
The SynCore Biotechnology Co FCF Growth history
YEARFCF GrowthYoY
22.05 %-45.17%
40.22 %-33.56%
60.53 %+572.14%
9.01 %-68.12%
28.25 %+19.90%
23.56 %-144.16%
-53.36 %+86.91%
-28.55 %+366.47%
-6.12 %-77.88%
-27.67 %-175.86%
36.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SynCore Biotechnology Co Stock analysis

What does SynCore Biotechnology Co do? SynCore Biotechnology Co Ltd, based in Dongshan, Yilan, Taiwan, operates in the Health Care sector with a focus on Pharmaceuticals. The company develops new drugs and integrates technology, employing 50 full-time staff. Its main product is SB03 Veregen, alongside research and development of anticancer drugs SB01 (injection and oral forms). SynCore primarily distributes its products within Taiwan. SynCore Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SynCore Biotechnology Co stock

Year-over-Year Free Cash Flow Growth of SynCore Biotechnology Co is 22.05 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth SynCore Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's SynCore Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — SynCore Biotechnology Co

All Key Metrics — SynCore Biotechnology Co